Suppr超能文献

相似文献

2
X-linked infantile spinal muscular atrophy: clinical definition and molecular mapping.
Genet Med. 2007 Jan;9(1):52-60. doi: 10.1097/gim.0b013e31802d8353.
3
Clinical and neuropathological features of X-linked spinal muscular atrophy (SMAX2) associated with a novel mutation in the UBA1 gene.
Neuromuscul Disord. 2013 May;23(5):391-8. doi: 10.1016/j.nmd.2013.02.001. Epub 2013 Mar 18.
4
A novel Xp11.22-22.33 deletion suggesting a possible mechanism of congenital cervical spinal muscular atrophy.
Mol Genet Genomic Med. 2021 Mar;9(3):e1606. doi: 10.1002/mgg3.1606. Epub 2021 Jan 29.
5
X-linked infantile spinal muscular atrophy.
Am J Dis Child. 1988 Feb;142(2):217-9. doi: 10.1001/archpedi.1988.02150020119045.
7
X-linked infantile spinal muscular atrophy (SMAX2) caused by novel c.1681G>A substitution in the UBA1 gene, expanding the phenotype.
Neuromuscul Disord. 2020 Jan;30(1):35-37. doi: 10.1016/j.nmd.2019.11.004. Epub 2019 Nov 14.
9
X-linked spinal muscular atrophy (SMAX2) caused by de novo c.1731C>T substitution in the UBA1 gene.
Neuromuscul Disord. 2015 Aug;25(8):661-6. doi: 10.1016/j.nmd.2015.05.001. Epub 2015 May 8.
10
Functional characterizations of rare variants in X-linked Spinal Muscular Atrophy.
F1000Res. 2017 Sep 4;6:1636. doi: 10.12688/f1000research.11878.1. eCollection 2017.

引用本文的文献

1
VEXAS: A review of current understandings and emerging treatment strategies.
Front Immunol. 2025 Jul 28;16:1644404. doi: 10.3389/fimmu.2025.1644404. eCollection 2025.
3
Utilizing Spermatogenesis and Fertilization Mutants as a Model for Human Disease.
J Dev Biol. 2025 Jan 25;13(1):4. doi: 10.3390/jdb13010004.
4
A novel UBA1 gene mutation in a patient with infantile respiratory distress syndrome.
Hum Genome Var. 2025 Jan 6;12(1):2. doi: 10.1038/s41439-024-00307-7.
5
Update on Inherited Pediatric Motor Neuron Diseases: Clinical Features and Outcome.
Genes (Basel). 2024 Oct 21;15(10):1346. doi: 10.3390/genes15101346.
7
dysfunction in VEXAS and cancer.
Oncotarget. 2024 Sep 30;15:644-658. doi: 10.18632/oncotarget.28646.
10
Ubiquitin system mutations in neurological diseases.
Trends Biochem Sci. 2024 Oct;49(10):875-887. doi: 10.1016/j.tibs.2024.06.011. Epub 2024 Jul 6.

本文引用的文献

1
Most rare missense alleles are deleterious in humans: implications for complex disease and association studies.
Am J Hum Genet. 2007 Apr;80(4):727-39. doi: 10.1086/513473. Epub 2007 Mar 8.
3
X-linked infantile spinal muscular atrophy: clinical definition and molecular mapping.
Genet Med. 2007 Jan;9(1):52-60. doi: 10.1097/gim.0b013e31802d8353.
4
The roles of intracellular protein-degradation pathways in neurodegeneration.
Nature. 2006 Oct 19;443(7113):780-6. doi: 10.1038/nature05291.
5
Gigaxonin-controlled degradation of MAP1B light chain is critical to neuronal survival.
Nature. 2005 Nov 10;438(7065):224-8. doi: 10.1038/nature04256. Epub 2005 Oct 16.
8
Ubiquitin, proteasome and parkin.
Biochim Biophys Acta. 2004 Nov 29;1695(1-3):235-47. doi: 10.1016/j.bbamcr.2004.09.026.
9
The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
Trends Cell Biol. 2004 Dec;14(12):703-11. doi: 10.1016/j.tcb.2004.10.006.
10
Degradation of survival motor neuron (SMN) protein is mediated via the ubiquitin/proteasome pathway.
Neurochem Int. 2004 Dec;45(7):1107-12. doi: 10.1016/j.neuint.2004.04.005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验